Karin Voll

Karin Voll is a seasoned chemist with extensive experience in process development across various industries, including pharmaceuticals and specialty chemicals. Currently serving as the Principal Process Development Chemist at Corden Pharma since November 2017, Karin has played a key role in optimizing processes for active pharmaceutical ingredients and has supported the development of synthetic amino lipids for mRNA vaccines during the pandemic. Prior experience includes significant contributions at Boulder Scientific Company, where Karin developed new synthetic procedures, and positions at Ribozyme Pharmaceuticals, the Arizona Department of Public Safety, and Lexmark, where various laboratory and support roles were undertaken. Karin holds a Bachelor's degree in Biology from the University of Colorado Boulder.